NCAM1 and Miyoshi myopathy: Previous experimentations have verified an augmented amount of CD56+ CD3− NK cells in the bone marrow and peripheral blood in MM patients and subjects with monoclonal gammopathy of undetermined significance (MGUS), a clinical precursor condition leading to MM.